Liquid formulation comprising an agonist of the alpha-2 receptors (eg, clonidine) and oxybutynin (antimuscarinic agent) for the treatment of sialorrhea
- 专利权人:
- Orient Pharma (Samoa) Co; Ltd
- 发明人:
- Roach, Alan Geoffrey,Goldsmith, Paul
- 申请号：
- ES12181773
- 公开号：
- ES2624577T3
- 申请日:
- 2007.02.12
- 申请国别(地区):
- ES
- 年份:
- 2017
- 代理人:
- 摘要：
- A liquid formulation comprising: a) clonidine； b) oxybutynin； and c) excipients.Una formulación líquida que comprende: a) clonidina； b) oxibutinina； y c) excipientes.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- LIQUID FORMULATION COMPRISING AN ALPHA-2 RECEPTOR AGONIST (E.G. CLONIDIN) AND OXYBUTYNIN (ANTI-MUSCARINIC AGENT) FOR THE TREATMENT OF SIALORRHOEA
- Combination of alpha-2 receptor agonist (clonidine) and antimuscarinic agent (oxybutynin) for the treatment of fluency
- LIQUID FORMULATING INCLUDING AN ALPHA-2 RECEPTOR AGONIST (E.g. CLONIDIN) AND OXYBUTYNIN (ANTIMUS CARININE) FOR THE TREATMENT OF SPIT
- FORMULATION LIQUIDE COMPRENANT UN AGONISTE DU RÉCEPTEUR ALPHA-2 (PAR.EX. CLONIDINE) ET OXYBUTYNINE (AGENT ANTI-MUSCARINIQUE) POUR LE TRAITEMENT DE LA SIALORRHÉE
- FORMULATIONS PHARMACEUTIQUES D'ANTICORPS DE TNF-ALPHA
